2022
DOI: 10.1016/j.jcjd.2022.09.029
|View full text |Cite
|
Sign up to set email alerts
|

Real-life Application of Peripartum in-Control Algorithm Use for Automated Insulin Delivery: A Case Series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The improvements in glucose outcomes with hybrid closed loop are replicated in a case series of pregnant women with type 1 diabetes in this issue 3 . The data from a small case series of off‐label use of the Control‐IQ algorithm reflect the outcomes from people outside of pregnancy but additionally offer insights into the experience of pregnancy with a hybrid closed loop.…”
mentioning
confidence: 76%
See 1 more Smart Citation
“…The improvements in glucose outcomes with hybrid closed loop are replicated in a case series of pregnant women with type 1 diabetes in this issue 3 . The data from a small case series of off‐label use of the Control‐IQ algorithm reflect the outcomes from people outside of pregnancy but additionally offer insights into the experience of pregnancy with a hybrid closed loop.…”
mentioning
confidence: 76%
“…The improvements in glucose outcomes with hybrid closed loop are replicated in a case series of pregnant women with type 1 diabetes in this issue. 3 The data from a small case series of off-label use of the Control-IQ algorithm reflect the outcomes from people outside of pregnancy but additionally offer insights into the experience of pregnancy with a hybrid closed loop. The women reported satisfaction from optimised glucose, improved sleep and reduced self-management burden with the system but notably also felt that, post-partum, staff were unfamiliar with the system with frustrations and negative feelings for the users.…”
mentioning
confidence: 99%
“…Until now, most studies on APS use in pregnant women with T1DM have been case reports, [12][13][14][15][16][17][18][19][20][21][22][23][24] with only a few available randomized controlled trials (RCTs) [25][26][27][28] and non-RCTs that have small sample sizes. 29,30 We conducted the present meta-analysis of the few RCTs to assess the efficacy of APS use among pregnant women with T1DM.…”
Section: Introductionmentioning
confidence: 99%